PeploBio is a specialist CRO supporting pharmaceutical, biotech, and diagnostic partners in the development and clinical validation of biomarker-driven assays.
We combine scientific depth with operational agility to translate complex biology into clinically validated tools. Our expertise spans immune monitoring, advanced biomarker analysis, assay development, and regulatory support — with a strong track record delivering studies across FDA, IVDR, and UKCA frameworks.

Our Services:
- Biomarker Analysis & Translational Research
- Advanced profiling of protein and molecular biomarkers to support clinical development and mechanistic insight
- Immune Monitoring
- Custom flow cytometry and Mass Spec services 
- Assay Development & Validation
- Design, optimisation, and validation of assays across RUO, LDT, and regulatory pathways
- Regulatory Strategy & Clinical Studies
- Design and execution of analytical and clinical performance studies aligned with IVDR, FDA, and UKCA requirements

Why PeploBio?
- Trusted partner to translational medicine teams, biotech innovators, and diagnostic manufacturers
- Expertise spanning early discovery through to late-stage clinical validation
- Biomarker and assay platform expertise across immunology, metabolic disease, and complex biology
- Agile team with global reach: London (UK), Cyprus (EU), and North Carolina (US)

PeploBio

Org chart

Teams

Offices

PeploBio

Org chart

Teams

Offices

Related companies